Osteopore
- Short interest
- 0.00%
- −0.16 pp 30d
- as of 14 June 2023
- Reported shorts
- 4.1K
- Shares on issue
- 144.229M
Osteopore (OSX) financials
Results, ratios and statements
Latest result
Half year to 30 Jun 2026 (HY26), figures in AUD, the reporting currency · Company filing, 31 Aug 2026
- Revenue
- $1.4MF (source: Company filing (extracted))vs n/a
- Company filing (extracted), as at 11 Oct 2026
- NPAT
- −$2.0MF (source: Company filing (extracted))vs n/a
- Company filing (extracted), as at 11 Oct 2026
- EPS (basic)
- n/avs n/a
- Rev YoY
- +5.0%FY
- EPS YoY
- n/aTTM
- Company filing (extracted)
Summary of Half Yearly Report and Accounts, 31 Aug 2026
Osteopore's half-year revenue fell 8% to $1.4M, while net loss widened 14% to $2.0M. No dividend was declared. The company continues investing in regulatory and market expansion, with revenue decline partly due to a stronger Australian dollar.
Automated summary of the filing; the filing itself is the record.
Key ratios
Year to 31 Dec 2025 (FY); balance sheet at 31 Dec 2025; prices to 14 Oct 2026
- Gross margin
- 77.5%
- Operating margin
- −111.6%
- Net margin
- −121.8%
- FCF margin
- −83.5%
- ROE
- n/a
- ROA
- −126.0%
- FCF conversion
- n/a
- Net debt (excl. leases)
- $2.0M
- Net debt / EBITDA
- n/a
- Current ratio
- 0.8×
- Interest cover
- −12.2×
- Cash dividends paid / net profit
- n/a
- Market cap
- $1.1M
- P/E
- n/a
- P/B
- n/a
Ratios use the reporting currency (AUD); market cap is in AUD. Source: Yahoo Finance, as at 14 Oct 2026.
Financial statements
Figures in AUD, the reporting currency; Yahoo Finance unless marked
| Line item | FY25 | FY24 | FY23 | FY22 |
|---|---|---|---|---|
| Revenue | $3.1M | $2.9M | $2.2M | $1.7M |
| Gross profit | $2.4M | $2.4M | $1.6M | $1.3M |
| Operating income | −$3.4M | −$2.9M | −$5.0M | −$4.5M |
| EBITDA | −$2.9M | −$2.4M | −$4.3M | −$4.0M |
| EBIT | −$3.4M | −$2.9M | −$4.8M | −$4.2M |
| Interest expense | $280.0K | $426.0K | $15.0K | $20.4K |
| Pretax income | −$3.7M | −$3.3M | −$4.8M | −$4.2M |
| Tax | $1.7K | $19.2K | $43.5K | $0 |
| NPAT | −$3.7M | −$3.4M | −$4.9M | −$4.2M |
| Net interest income | −$275.3K | −$426.0K | −$7.5K | −$20.4K |
| EPS basic | −$0.020T (source: Derived: trailing 12 months at year end) | −$0.030 | −$0.084 | −$0.090 |
| EPS diluted | −$0.020T (source: Derived: trailing 12 months at year end) | −$0.030 | −$0.084 | −$0.090 |
| Shares | 272.5M | 116.8M | 57.8M | 46.7M |
- Derived: trailing 12 months at year end
Financial reports
The company's own filings, newest first
- Half Yearly Report and AccountsHalf Year Results31 Aug 2026via asx_announcements
Figures above come from this filing
- Activities Report June 2026 and Appendix 4CQuarterly Report31 Jul 2026via asx_announcements
- Activities Report March 2026 and Appendix 4CQuarterly Report30 Apr 2026via asx_announcements
- Annual Report to ShareholdersAnnual Report31 Mar 2026via asx_announcements
- Appendix 4E Preliminary Final ReportAnnual Results27 Feb 2026via asx_announcements
- Activities Report December 2025 and Appendix 4CQuarterly Report30 Jan 2026via asx_announcements
- Activities Report September 2025 and Appendix 4CQuarterly Report31 Oct 2025via asx_announcements
- Half Yearly Report and AccountsHalf Year Results29 Aug 2025via asx_announcements
- Activities Report June 2025 and Appendix 4CQuarterly Report31 Jul 2025via asx_announcements
- Activities Report March 2025 and Appendix 4CQuarterly Report29 Apr 2025via asx_announcements
Showing 10 of 75 reports